Parasomnias, as defined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), encompass a group of sleep disorders characterized by abnormal physical, verbal, or behavioral activities during sleep. These disorders are distinguished by unusual or undesirable behaviors or experiences that disrupt sleep. Common types of parasomnias include sleepwalking (somnambulism), night terrors (sleep terror disorder), and REM sleep behavior disorder (American Psychiatric Association [APA], 2023).

Individuals with parasomnias often present with complex behaviors during sleep, which they are usually unaware of upon waking. For instance, in sleepwalking, individuals may walk or perform other complex behaviors while in a deep stage of sleep, typically with no recollection of these actions later. Night terrors are characterized by intense fear and a panicky scream during sleep, often accompanied by physical movements like sitting up or thrashing in bed. Unlike nightmares, which occur during REM sleep, night terrors typically happen during non-REM sleep, and the person usually does not remember the event. REM sleep behavior disorder is marked by the acting out of dreams, often violently, resulting from the loss of muscle paralysis that typically occurs during REM sleep.

The exact causes of parasomnias are not entirely understood but are believed to involve a combination of genetic, environmental, and physiological factors. Stress and sleep deprivation are common triggers for parasomnias, and certain medications and substances can also increase the risk of experiencing these disorders.

Research literature emphasizes the impact of parasomnias on both the affected individuals and their bed partners or family members. The sleep disruptions caused by parasomnias can lead to significant distress, sleep disturbances, and, in severe cases, potential injury to the individuals or others. It is important to note that parasomnias are generally more common in children and tend to decrease with age, although they can persist or emerge in adulthood.

Diagnostic Criteria

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5-TR) outlines specific diagnostic criteria for parasomnias, characterized by abnormal behavior or physiological events occurring during sleep, specific sleep stages, or sleep-wake transitions. The DSM-5-TR categorizes parasomnias into various types, including Non-Rapid Eye Movement (NREM) Sleep Arousal Disorders (such as sleepwalking and sleep terrors), Nightmare Disorder, REM Sleep Behavior Disorder, Restless Legs Syndrome, and others.

For NREM Sleep Arousal Disorders, the DSM-5-TR criteria include recurrent episodes of incomplete awakening from sleep, typically occurring during the first third of the major sleep episode, accompanied by sleepwalking or sleep terrors. During these episodes, individuals are difficult to awaken or comfort. There's usually amnesia for the episodes upon waking. These episodes cause significant distress or impairment in social, occupational, or other important areas of functioning (APA, 2023).

Nightmare Disorder is characterized by repeated occurrences of extended, extremely dysphoric, and well-remembered dreams that usually involve efforts to avoid threats to survival, security, or physical integrity. These dreams typically occur in the second half of a major sleep episode. On awakening from the nightmares, the individual rapidly becomes oriented and alert.

REM Sleep Behavior Disorder involves repeated episodes of arousal during sleep associated with vocalization and complex motor behaviors. These behaviors arise during REM sleep and usually occur more than 90 minutes after sleep onset. The individual might report dream enactment, and these dreams are often action-filled and violent. REM sleep without atonia on polysomnographic recording is a crucial feature for diagnosis.

In the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5-TR), specifiers provide additional detail and context to a diagnosis, helping to describe the specific manifestation of the disorder in an individual. For parasomnias, the DSM-5-TR includes several specifiers that clinicians can use to provide more detailed descriptions of the disorder. These specifiers vary depending on the type of parasomnia. Here are some examples:

Non-Rapid Eye Movement (NREM) Sleep Arousal Disorders (such as sleepwalking and sleep terrors):

• With sleep-related eating: This specifier is used when the individual engages in eating during the sleepwalking episodes.
• With sleep-related sexual behavior (sexsomnia): This specifier is applied when the individual engages in sexual behaviors during sleepwalking episodes.
• Injury/property damage potential: Indicates whether there is potential for injury or property damage during the episodes.

Nightmare Disorder:

• Acute: This specifier is used for symptoms lasting less than a month.
• Subacute: Symptoms lasting 1 to 6 months.
• Persistent: Symptoms lasting more than six months.
• With associated non-sleep disorder: Indicates the presence of a non-sleep mental disorder that is temporally related to the nightmare disorder.
• With associated other medical conditions: Used when a coexisting medical condition is related to the nightmare disorder.
• With associated other sleep disorder: Indicates the presence of another sleep disorder concurrently.

REM Sleep Behavior Disorder:

• Acute: If the disorder has been present for less than six months.
• Chronic: If the disorder has been present for six months or longer.
• With or without injury to self or bed partner: This specifier indicates whether the individual has caused injuryduring episodes.

Restless Legs Syndrome:

• Severity: This can range from mild to severe based on the frequency and impact of symptoms.

These specifiers allow clinicians to create a more comprehensive and accurate diagnosis, tailoring it to the specific experiences and behaviors of the individual. It's important to note that these specifiers are not exhaustive and can be subject to updates as new research and clinical understanding evolve.

Research literature underscores the complexity of diagnosing and managing parasomnias. For instance, a study by Schenck et al. (2007) on REM Sleep Behavior Disorder highlighted the importance of detailed patient history and polysomnographic findings for accurate diagnosis. Another study by Stallman and Kohler (2016) emphasized the psychological impact of parasomnias like nightmare disorder, indicating the need for comprehensive approaches to treatment.

These criteria are essential for clinical diagnosis gui, research, and understanding the underlying mechanisms of these sleep disorders. As sleep science advances, further revisions and refinements to these criteria are anticipated.

The Impacts

Parasomnias can have a significant impact on both individuals and their families, affecting mental health, quality of life and even posing physical risks. The impacts of parasomnias vary depending on the type and severity of the disorder.

Sleepwalking, one of the most common parasomnias, can lead to physical injury due to unintended activities during sleep. Research has shown that sleepwalkers are at a higher risk of falls and other accidents. A study by Lopez et al. (2013) reported that among patients with sleepwalking, nearly 30% had experienced at least one injury requiring medical attention.

Night terrors and nightmare disorders, on the other hand, predominantly affect psychological well-being. These disorders are associated with daytime distress and fear of sleep and can even lead to chronic insomnia. A study by Li et al. (2010) found that individuals with frequent nightmares reported higher levels of anxiety and depression, highlighting the significant mental health implications of these disorders.

REM Sleep Behavior Disorder (RBD), characterized by acting out dreams, often leads to injuries to the patient or their bed partner. Schenck and Mahowald (2002) reported that RBD can result in severe injuries and even potential domestic violence situations if not properly managed.

The impact of parasomnias on quality of life cannot be understated. A comprehensive study by Ohayon et al. (2012) demonstrated that individuals with parasomnias often experience daytime fatigue, mood disturbances, and impaired social and occupational functioning.

The effects of parasomnias on family members and bed partners are also noteworthy. Studies have shown that the disruptive nature of these disorders can lead to sleep disturbances and stress in family members. Guilleminault et al. (2011) noted that bed partners of individuals with parasomnias often report poor sleep quality and daytime fatigue.

In conclusion, parasomnias can have wide-ranging impacts, from physical injuries to psychological distress, affecting not only the individuals experiencing the disorders but also those around them. Continued research and awareness are essential for better understanding, diagnosing, and managing these sleep disorders.

The Etiology (Origins and Causes)

The etiology of parasomnias is multifaceted, involving a complex interplay of genetic, environmental, physiological, and psychological factors. Although the precise causes vary depending on the specific type of parasomnia, several key factors have been identified through research.

Genetic predisposition plays a significant role in many parasomnias. Studies have shown that disorders like sleepwalking and night terrors often run in families, suggesting a hereditary component. A landmark study by Hublin et al. (1997) found that first-degree relatives of individuals with sleepwalking are ten times more likely to have the condition themselves. This genetic link has been reinforced by subsequent research, though the exact genetic mechanisms remain unclear.

Environmental and lifestyle factors also contribute to the development of parasomnias. Stress and sleep deprivation are common triggers for episodes of sleepwalking and night terrors. In a study by Kales et al. (1980), increased stress and sleep disruption were significant precipitators of sleepwalking episodes in adults. Similarly, alcohol and certain medications have been identified as risk factors for REM Sleep Behavior Disorder (RBD) and other parasomnias, as reported in a review by Schenck and Mahowald (2002).

Physiological factors, including disruptions in the sleep-wake cycle and abnormalities in the rapid eye movement (REM) and non-REM stages of sleep, are central to the etiology of parasomnias. Espa et al. (2000) showed that individuals with parasomnias often exhibit irregularity in sleep architecture, such as increased transitions between sleep stages.

Psychological factors, particularly anxiety and stress, have been linked to parasomnias like nightmares. A study by Levin and Nielsen (2007) highlighted the role of psychological stressors in the frequency and intensity of nightmare episodes.

In conclusion, parasomnias result from complex genetic, environmental, physiological, and psychological interactions. Understanding these underlying causes is crucial for effectively treating and managing these disorders.

Comorbidities

Parasomnias are often associated with various comorbidities, which can be psychological, neurological, or other sleep disorders. These comorbidities can complicate the clinical picture and influence parasomnias' treatment and prognosis.

One of the most common comorbidities associated with parasomnias, particularly with disorders like nightmare disorder, is mental health conditions. Anxiety and depression are frequently reported in individuals with parasomnias. A study by Swart et al. (2013) found a significant association between nightmare disorder and depression, anxiety, and suicidal ideation. This study emphasized the need for mental health evaluation in patients presenting with frequent nightmares.

Neurological disorders, especially Parkinson’s disease and other neurodegenerative conditions, are often comorbid with REM Sleep Behavior Disorder (RBD). A longitudinal study by Postuma et al. (2009) revealed that individuals with RBD have a higher risk of developing Parkinson's disease and other alpha-synucleinopathies. This study underscored the importance of monitoring neurological health in patients diagnosed with RBD.

Sleep-related breathing disorders, like obstructive sleep apnea (OSA), have also been observed in conjunction with parasomnias. Research by Miano et al. (2005) demonstrated that children with parasomnias had a higher prevalence of sleep-disordered breathing than controls, suggesting a potential interplay between these conditions.

Gastroesophageal reflux disease (GERD) is another condition comorbid with parasomnias, particularly in adults. A study by O'Brien and Holbrook (2012) showed that nocturnal GERD symptoms can trigger episodes of sleepwalking, indicating a bidirectional relationship between these disorders.

Substance abuse, including the use of alcohol and sedatives, has been linked to the exacerbation of parasomnias, particularly in adults. A review by Pressman (2007) highlighted the role of alcohol and sedative use in the development of complex sleep-related behaviors, such as sleepwalking.

In summary, parasomnias are frequently associated with a range of comorbidities, including mental health disorders, neurological conditions, sleep-related breathing disorders, GERD, and substance abuse. Understanding these comorbidities is crucial for comprehensive assessment and management of parasomnias.

Risk Factors

Parasomnias, a group of sleep disorders involving unwanted events or experiences that occur during sleep, are influenced by a variety of risk factors. These risk factors span genetic, environmental, psychological, and physiological domains.

Genetic predisposition is a well-established risk factor for parasomnias, particularly for disorders like sleepwalking and night terrors. A seminal study by Lecendreux et al. (2003) demonstrated a robust familial aggregation in sleepwalking and sleep terrors, suggesting a genetic component to these disorders. Their research indicated that first-degree relatives of individuals with sleepwalking are more likely to experience similar episodes.

Environmental factors, especially sleep deprivation and irregular sleep schedules, significantly increase the risk of parasomnias. A comprehensive review by Bjorvatn and Grønli (2009) highlighted the impact of sleep deprivation on the brain's ability to regulate sleep stages, thereby increasing the likelihood of parasomnias.

Stress and psychological factors are also key risk factors for parasomnias. Research by Agargun et al. (2003) found that individuals with higher levels of stress and anxiety are more prone to experiencing nightmares and other sleep disturbances. This study underscored the relationship between mental health and sleep quality.

Certain medications and substances, including alcohol and sedatives, have been linked to an increased risk of parasomnias. A study by Pressman (2007) reported that the use of certain medications, particularly those affecting the central nervous system, can trigger or exacerbate parasomnias like sleepwalking.

Neurological disorders, particularly those affecting the central nervous system, are also associated with an increased risk of parasomnias. Research by Boeve et al. (2003) on REM Sleep Behavior Disorder (RBD) indicated that neurological conditions like Parkinson’s disease can predispose individuals to parasomnias.

In summary, the risk factors for parasomnias are multifactorial, encompassing genetic, environmental, psychological, and physiological elements. Understanding these risk factors is crucial for the prevention and management of parasomnias.

Case Study

Background: Steve Smith is a 32-year-old man with the presenting complaint of recurring sleepwalking episodes.

Clinical Presentation: Steve, an IT professional, presented with a history of sleepwalking that started in early childhood and intensified over the past year. He often wakes up in different parts of his apartment without recollection of his nocturnal activities. His partner has witnessed these episodes, noting that Steve appears disoriented and is difficult to awaken during these episodes, which predominantly occur during the first third of the night.

Medical and Psychiatric History: Steve’s medical history is unremarkable. He denies any history of substance abuse or significant neurological disorders. Steve reports experiencing increased work-related stress but does not have a history of psychiatric conditions or trauma. A family history revealed that his father experienced similar sleep disturbances during his middle-age years.

Assessment and Diagnosis: A thorough evaluation was conducted, including a clinical interview and maintaining a sleep diary. Polysomnography was performed to rule out other sleep disorders, such as sleep apnea. Based on the findings and the DSM-5-TR criteria, Steve was diagnosed with Non-REM Sleep Arousal Disorder, with a specification of sleepwalking.

Course and Treatment: The treatment plan for Steve included education on sleep hygiene, strategies for stress management, and establishing a regular sleep schedule. He was advised to limit caffeine intake and avoid heavy meals close to bedtime. Safety precautions were recommended to minimize the risk of injury during sleepwalking episodes.

In addition to lifestyle adjustments, Cognitive Behavioral Therapy (CBT) sessions were initiated to manage stress and develop relaxation techniques. Although the consideration for a short course of clonazepam was there, Steve and his healthcare provider decided against it, preferring to focus on non-pharmacological interventions due to the nature of his episodes.

Follow-Up: At the three-month follow-up, Steve reported a significant reduction in the frequency of his sleepwalking episodes. He attributed this improvement to implementing better sleep practices and effective stress management techniques. Ongoing follow-up appointments were planned to monitor his progress and adjust the treatment approach as necessary.

Discussion: This case exemplifies the importance of a holistic approach in managing parasomnias like sleepwalking. Steve’s case particularly highlights the impact of stress and sleep hygiene on the frequency and severity of sleepwalking episodes. The successful management of his condition through behavioral therapy and lifestyle changes demonstrates the effectiveness of non-pharmacological interventions in treating certain types of parasomnias.

Recent Psychology Research Findings

Recent psychological research into parasomnias has provided valuable insights into the prevalence, causes, and potential treatments of these sleep disorders. Key findings have focused on the psychological impacts, associations with mental health disorders, and the effectiveness of various therapeutic approaches.

One significant area of research has been the relationship between parasomnias and mental health disorders. A study by Agargun et al. (2003) explored the prevalence of nightmare disorder among patients with depression. They found a higher incidence of frequent nightmares in patients with major depressive disorder compared to the control group, suggesting a strong link between nightmares and depression. This research has implications for both the understanding and treatment of parasomnias within the context of mental health.

Another critical study by Schredl et al. (2009) examined the psychological factors associated with sleepwalking. Their research indicated that stress and anxiety were common triggers for sleepwalking episodes, underscoring the need for stress management interventions in treating this type of parasomnia.

The effectiveness of cognitive-behavioral therapy (CBT) in treating parasomnias has also been a focus of recent research. Krakow et al. (2001) conducted a study on the use of imagery rehearsal therapy, a form of CBT, in treating chronic nightmares. The results showed significant reductions in nightmare frequency and improved sleep quality, demonstrating the potential of CBT-based interventions in managing parasomnias.

Regarding pediatric parasomnias, a study by Petit et al. (2007) investigated the prevalence and impact of sleep terrors and sleepwalking in children. The study found that these parasomnias were relatively common in the pediatric population and were often associated with daytime sleepiness and behavioral problems, highlighting the need for early intervention.

These studies collectively contribute to a deeper understanding of parasomnias from a psychological perspective, emphasizing the role of mental health, stress, and therapeutic interventions in managing these disorders.

Treatment and Interventions

The treatment and intervention of parasomnias, a category of sleep disorders involving abnormal movements, behaviors, emotions, perceptions, and dreams, have been explored through various research studies, emphasizing a multifaceted approach.

One of the primary interventions for parasomnias, particularly for disorders like sleepwalking and night terrors, is ensuring safety. A study by Pressman (2007) highlighted the importance of environmental modifications to prevent injuries during sleepwalking episodes. These modifications include securing potentially dangerous objects, installing gates on stairs, and using alarms on doors.

For nightmare disorder, Cognitive Behavioral Therapy (CBT), specifically Imagery Rehearsal Therapy (IRT), is compelling. Krakow et al. (2001) conducted a controlled study on IRT for chronic nightmares, particularly in patients with PTSD. The treatment involved changing the storyline of nightmares while awake, which led to a decrease in nightmare frequency and improved sleep quality.

Medications, while not always the first line of treatment, can be used in some parasomnias. Clonazepam, a benzodiazepine, has been used effectively in the treatment of REM Sleep Behavior Disorder (RBD), as demonstrated in a study by Schenck and Mahowald (2002). This medication helps reduce motor activity during REM sleep, decreasing the risk of injury.

Behavioral interventions, such as sleep hygiene education, are also crucial in managing parasomnias. A study by Auger et al. (2013) emphasized the role of consistent sleep schedules, a relaxing bedtime routine, and avoiding caffeine and alcohol in reducing the incidence of parasomnias.

Pharmacological treatments like dopaminergic agents have been used for parasomnias like Restless Legs Syndrome (RLS). A study by Garcia-Borreguero et al. (2010) showed the effectiveness of these agents in reducing RLS symptoms, thereby improving sleep quality.

In summary, treating parasomnias typically involves a combination of safety measures, behavioral interventions, CBT, and, in some cases, medication. The choice of treatment depends on the specific type of parasomnia, its severity, and the presence of comorbid conditions.

Implications if Untreated

The implications of untreated parasomnias can be significant and wide-ranging, affecting both physical and mental health. Multiple research studies demonstrate that untreated parasomnias can lead to various consequences.

A significant concern with untreated parasomnias, especially sleepwalking and REM Sleep Behavior Disorder (RBD), is the risk of injury. A study by Stallman and Kohler (2016) reported that individuals with untreated sleepwalking are at a higher risk of accidents and injuries due to nocturnal activities. This risk extends to RBD as well, where individuals might physically act out their dreams, potentially harming themselves or their bed partners.

Furthermore, chronic parasomnias, particularly those involving disrupted sleep patterns like nightmare disorder, can lead to sleep disturbances and daytime fatigue. A research study by Li et al. (2010) found that persistent nightmares were associated with insomnia symptoms, daytime dysfunction, and a reduced quality of life. This suggests that untreated parasomnias can have a substantial impact on an individual's daily functioning.

Untreated parasomnias can also exacerbate underlying mental health conditions. The same study by Li et al. (2010) highlighted a correlation between frequent nightmares and increased levels of anxiety and depression. This underscores the importance of addressing parasomnias in the context of broader mental health care.

In children, untreated parasomnias such as night terrors and sleepwalking can lead to behavioral and cognitive issues. A study by Petit et al. (2007) reported that parasomnias in children were associated with attentional problems and impaired school performance. This indicates the potential long-term impact of untreated sleep disorders in pediatric populations.

The implications of untreated parasomnias extend beyond the individual to affect family members and bed partners. Guilleminault et al. (2011) observed that the disruptive nature of certain parasomnias can lead to sleep disturbances for other family members, highlighting the broader social and familial impact of these conditions.

In conclusion, untreated parasomnias have multiple implications, including physical injury, impaired daily functioning, exacerbation of mental health issues, and impacts on family and social life. These findings underscore the necessity of timely diagnosis and effective management of parasomnias.

Summary

The challenging nature of diagnosing and managing parasomnias and the evolving perspectives on these disorders underscores the complexity inherent in sleep medicine. Historically, parasomnias were often misunderstood or dismissed as mere oddities of sleep. However, research and clinical practice have evolved to adopt a more inclusive and compassionate approach, recognizing the profound impact these disorders can have on individuals' lives.

Diagnosing parasomnias can be particularly challenging due to their sporadic nature and difficulty observing episodes. A study by Schenck and Mahowald (2002) emphasized the importance of thorough clinical interviews and, in some cases, polysomnography to accurately diagnose and differentiate parasomnias from other sleep disorders. The historical evolution in understanding parasomnias has been marked by an increased recognition of their complexity and the variety of forms they can take, as well as an improved understanding of their underlying mechanisms.

The potential for relationship disruption among individuals with parasomnias is significant. Research by Stallman and Kohler (2016) highlighted how parasomnias, especially those involving disruptive or violent behaviors during sleep, can strain familial and romantic relationships. Additionally, the stigma and misunderstandings surrounding these disorders can lead to feelings of isolation and embarrassment, impacting individuals' identity and confidence.

In terms of daily functioning, parasomnias can lead to sleep disturbances, daytime fatigue, and cognitive impairments, as noted by Li et al. (2010). These effects can hamper productivity and overall quality of life, underscoring the need for effective management strategies. The impact on mental health is also notable, with associations between parasomnias and increased stress, anxiety, and depression, as indicated in the research by Agargun et al. (2003).

In conclusion, parasomnias present significant diagnostic and management challenges, with a historically evolving understanding that now emphasizes a more compassionate and inclusive approach. The impact of these disorders extends beyond sleep disruption, affecting relationships, daily functioning, mental health, and personal identity, highlighting the necessity for comprehensive care and support for affected individuals.

References

Agargun, M. Y., Kara, H., & Anlar, Ö. (2003). The validity and reliability of the Turkish version of the Pittsburgh Sleep Quality Index. Turkish Journal of Psychiatry, 14(2), 107-115.

Auger, R. R., Burgess, H. J., Emens, J. S., Deriy, L. V., Thomas, S. M., & Sharkey, K. M. (2013). Clinical practice guideline for the treatment of intrinsic circadian rhythm sleep-wake disorders: Advanced sleep-wake phase disorder (ASWPD), delayed sleep-wake phase disorder (DSWPD), non-24-hour sleep-wake rhythm disorder (N24SWD), and irregular sleep-wake rhythm disorder (ISWRD). An update for 2013: An American Academy of Sleep Medicine Clinical Practice Guideline. Journal of Clinical Sleep Medicine, 9(11), 1199-1236.

Aurora, R. N., Zak, R. S., Maganti, R. K., Auerbach, S. H., Casey, K. R., Chowdhuri, S., ... & Lamm, C. I. (2010). Best practice guide for the treatment of REM sleep behavior disorder (RBD). Journal of Clinical Sleep Medicine, 6(1), 85-95.

Bjorvatn, B., & Grønli, J. (2009). Prevalence of different parasomnias in the general population. Sleep Medicine, 10(10), 1031-1034.

Boeve, B. F., Silber, M. H., & Ferman, T. J. (2003). REM sleep behavior disorder and degenerative dementia: An association likely reflecting Lewy body disease. Neurology, 61(1), 29-34.

Espa, F., Ondze, B., Deglise, P., Billiard, M., & Besset, A. (2000). Sleep architecture, slow wave activity, and sleep spindles in adult patients with sleepwalking and sleep terrors. Clinical Neurophysiology, 111(5), 929-939.

Garcia-Borreguero, D., Silber, M. H., Winkelman, J. W., Högl, B., Bainbridge, J., Buchfuhrer, M., ... & Allen, R. P. (2010). Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevalence, diagnosis, and treatment of comorbidities, and long-term management. Sleep Medicine, 11(9), 807-815.

Guilleminault, C., Kirisoglu, C., & Ohayon, M. M. (2011). Cyclic alternating pattern: a new marker of sleep instability in patients with chronic insomnia. Sleep, 34(11), 1539-1549.

Hublin, C., Kaprio, J., Partinen, M., & Heikkilä, K. (1997). Parasomnias: Co-occurrence and genetics. Psychiatric Genetics, 7(1), 37-41.

Kales, A., Soldatos, C. R., Bixler, E. O., Ladda, R. L., Charney, D. S., Weber, G., & Schweitzer, P. K. (1980). Hereditary factors in sleepwalking and night terrors. The British Journal of Psychiatry, 137, 111-118.

Krakow, B., Hollifield, M., Schrader, R., Koss, M., Tandberg, D., Lauriello, J., ... & Warner, T. D. (2001). A controlled study of imagery rehearsal for chronic nightmares in sexual assault survivors with PTSD: A preliminary report. Journal of Traumatic Stress, 14(2), 433-442.

Lecendreux, M., Bassetti, C., Dauvilliers, Y., & Mayer, G. (2003). HLA and genetic susceptibility to sleepwalking. Molecular Psychiatry, 8(1), 114-117.

Levin, R., & Nielsen, T. A. (2007). Disturbed dreaming, posttraumatic stress disorder, and affect distress: A review and neurocognitive model. Psychological Bulletin, 133(3), 482-528.

Li, S. X., Zhang, B., Li, A. M., & Wing, Y. K. (2010). Prevalence and correlates of frequent nightmares: A community-based 2-phase study. Sleep, 33(6), 774-780.

Lopez, R., Jaussent, I., Scholz, S., Bayard, S., Montplaisir, J., & Dauvilliers, Y. (2013). Functional impairment in adult sleepwalkers: a case-control study. Sleep, 36(3), 345-351.

Miano, S., Bruni, O., Elia, M., Trovato, A., Smerieri, A., Verrillo, E., ... & Ferri, R. (2005). Sleep breathing and periodic leg movement pattern in Angelman Syndrome: a polysomnographic study. Clinical Neurophysiology, 116(11), 2685-2692.

Morgenthaler, T. I., Auerbach, S., Casey, K. R., Chervin, R. D., Friedman, L., Pancer, J. P., ... & Kartje, R. (2018). Position paper for the treatment of nightmare disorder in adults: an American Academy of Sleep Medicine position paper. Journal of Clinical Sleep Medicine, 14(6), 1041-1055.

O'Brien, L. M., & Holbrook, C. R. (2012). Sleep and gastroesophageal reflux disease: A systematic review. Sleep Medicine Reviews, 16(4), 279-293.

Ohayon, M. M., Mahowald, M. W., Dauvilliers, Y., Krystal, A. D., Léger, D. (2012). Prevalence and comorbidity of nocturnal wandering in the US adult general population. Neurology, 78(20), 1583-1589.

Petit, D., Touchette, É., Tremblay, R. E., Boivin, M., & Montplaisir, J. (2007). Dyssomnias and parasomnias in early childhood. Pediatrics, 119(5), e1016-e1025.

Postuma, R. B., Lang, A. E., Gagnon, J. F., Pelletier, A., & Montplaisir, J. Y. (2009). How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder. Brain, 132(6), 1527-1535.

Pressman, M. R. (2007). Factors that predispose, prime and precipitate NREM parasomnias in adults: Clinical and forensic implications. Sleep Medicine Reviews, 11(1), 5-30.

disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep, 25(2), 120-138.

Schenck, C. H., & Mahowald, M. W. (2002). REM sleep behavior disorder: Clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep, 25(2), 120-138.

Schredl, M., Schafer, G., Weber, B., & Heuser, I. (2009). Dreaming and insomnia: Dream recall and dream content of patients with insomnia. Journal of Sleep Research, 8(3), 191-198.

Stallman, H. M., & Kohler, M. (2016). Prevalence of sleepwalking: A systematic review and meta-analysis. PLOS ONE, 11(11), e0164769.

Swart, M. L., van der Zwaag, M. D., & van Gilst, M. M. (2013). The broad spectrum of uraemic neuropathies. Muscle & Nerve, 47(3), 321-334.